Jeffrey S. Painter

Mutations in the Fas Antigen in Patients With Multiple Myeloma

Terry H. Landowski, Ning Qu, I Buyuksal et al. · Blood · 1997 · 224 citations · Full text

Reduced natural killer (NK) function associated with high-risk myelodysplastic syndrome (MDS) and reduced expression of activating NK receptors

Pearlie K. Epling‐Burnette, Fanqi Bai, Jeffrey S. Painter et al. · Blood · 2007 · 219 citations · Full text

Mutations in the Fas Antigen in Patients With Multiple Myeloma

Terry H. Landowski, Ning Qu, I Buyuksal et al. · Blood · 1997 · 187 citations

GM-CSF–dependent pSTAT5 sensitivity is a feature with therapeutic potential in chronic myelomonocytic leukemia

Eric Padron, Jeffrey S. Painter, Sateesh Kunigal et al. · Blood · 2013 · 154 citations · Full text

Genotypic and phenotypic comparisons of de novo and acquired melphalan resistance in an isogenic multiple myeloma cell line model.

Lori Hazlehurst, Steven A. Enkemann, Craig A. Beam et al. · PubMed · 2003 · 143 citations

Hematological Malignancy, Tumor Biology, Melphalan Resistance +13